The value of iron treatment for postoperative obstetric patients with anemia: a randomized double blind controlled trial

The value of iron treatment for postoperative obstetric patients with anemia: a randomized double blind controlled trial - VITAPOP

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON44876

Enrollment

180

Registered

2014-01-27

Start date

2015-03-02

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

anemia iron-poor blood

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria;The patient has undergone a primary caesarean section;The postoperative hemoglobin is between 5-7 mmol / L

Exclusion criteria

Exclusion criteria: Exclusion Criteria;• Malignancy during pregnancy or during the first six weeks postpartum • HELLP syndrome • Pre-eclampsia • Infections • Bloodtransfusions during pregnancy or peri-or postoperative • Hematologic disorder (hemoglobinopathy; hemochromatosis) • Erythropoiesis-stimulating agents

Design outcomes

Primary

Measure	Time frame
primary: • Hemoglobin levels after 3 and 6 weeks	—

Secondary

Measure	Time frame
secondary: • Quality of life after 1, 3 and 6 weeks • Side effects of the medication • Predictive value of other parameters such as CRP, transferrin, ferritin and hepcidin • Cost-benefit analysis	—

Countries

Netherlands

Outcome results